Aidigong Maternal & Child Health : VOLUNTARY ANNOUNCEMENT DISPOSAL OF SUBSIDIARIES

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

愛 帝 宮 母 嬰 健 康 股 份 有 限 公 司

AIDIGONG MATERNAL & CHILD HEALTH LIMITED

(Incorporated in Bermuda with limited liability)

(Stock code: 286)

VOLUNTARY ANNOUNCEMENT

DISPOSAL OF SUBSIDIARIES

This announcement is made by Aidigong Maternal & Child Health Limited (the "Company", together with its subsidiaries, the "Group") on a voluntary basis to provide the shareholders of the Company ("Shareholders") and potential investors an update on the latest business development of the Group.

DISPOSAL OF SUBSIDIARIES

The board (the "Board") of directors (the "Directors") of the Company announces that it has recently, through its wholly-owned subsidiary, namely Guangzhou Common Splendor Health Technology Limited*（廣州同佳醫療科技有限公司）, completed the disposals (the "Disposals") of its entire interests in each of (i) Guangzhou Ruiang Comprehensive Clinic Co., Ltd.*（廣州瑞昂綜合門診部有限公司）("Guangzhou Ruiang Clinic"); (ii) Huizhou Common Splendor Medical Technology Co., Ltd.*（惠州市同佳醫療科技有限公司） ("Huizhou CS Medical Tech"); (iii) Shenzhen Common Splendor Clinic*（深圳同佳門診 部）("Shenzhen Clinic"); and (iv) Guangzhou Common Splendor Cell Technology Co., Ltd.* （廣州同佳細胞科技有限公司）("Guangzhou CS Cell Tech") ((i) to (iv), collectively, the

"Disposed Subsidiaries").

1

To the best of the Directors' knowledge, information and belief, having made all reasonable enquiry, the respective purchasers of the Disposed Subsidiaries' equity interests and their respective ultimate beneficial owners are a not connected person of the Company.

After the completion of the Disposals, the Company ceased to hold any interests in the Disposed Subsidiaries, and accordingly, the financial results of the Disposed Subsidiaries will no longer be consolidated into the Company's consolidated financial statements. It is expected that the Group will recognise a gain in its consolidated income statement of approximately RMB7.4 million, in aggregate, arising from the Disposals, which actual amount of gain arising from the Disposals to be recognised by the Group will be subject to final audit by the Company's auditors.

REASONS FOR AND BENEFITS OF THE DISPOSALS

The Group is principally engaged in the postpartum care services and health industry business. Postpartum care services primarily include provision of postpartum care services that provide healthcare services for postnatal mothers and babies, and the health industry business primarily includes medical anti-aging and healthcare industry investments.

As disclosed in the 2019 annual report of the Company, the Group intends to focus on the development of postpartum care service business as such segment greatly contributed to the Group's performance in terms of its sales and profit. The Board considers that the Disposals will enhance the Group's focus on its core business segments, and the Directors are of the view that the Disposals will improve the liquidity and overall financial position of the Group thereby creating greater value for the Shareholders. The Directors consider that terms of the Disposals are on normal commercial terms, and are fair and reasonable and in the interests of the Company and its Shareholders as a whole.

2

As none of the applicable percentage ratios in respect of the transactions contemplated under the Disposals exceeds 5%, the Disposals do not constitute a notifiable transaction under Chapter 14 of the Rules Governing the Listing of Securities on the Main Board of the Stock Exchange.

By Order of the Board

Aidigong Maternal & Child Health Limited

Zhu Yufei and Cheung Wai Kuen

Joint Chairmen

Hong Kong, 5 August 2020

As at the date of this announcement, the Board comprises Ms. Zhu Yufei, Mr. Cheung Wai Kuen, Mr. Lin Jiangand Mr. Li Runpingas executive Directors; Mr. Wong Kin Man and Mr. Yang Zhibo as non-executive Directors; and Mr. Mai Yang Guang, Mr. Lam Chi Wing and Mr. Wong Yiu Kit, Ernest as independent non-executive Directors.

• for identification purposes only

3